DexCom Execs Sued For Allegedly Misleading Growth Claims

Executives and directors of glucose monitor manufacturer DexCom Inc. have been hit with a derivative suit alleging that they concealed from investors that DexCom struggled to maintain a sales force that...

Already a subscriber? Click here to view full article